Interclean Shanghai

Toshiba’s Next Generation Advanced Image Processing for the Infinix-i increasing accuracy

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Toshiba America Medical Systems, Inc. has introduced Next Generation Advanced Image Processing (AIP) available on its Infinix™-i X-ray product line. Next Generation AIP was tested and evaluated by Dr. Vinit Lal, interventional cardiologist, HeartPlace, who noted the upgraded processor has increased accuracy and improved workflow and helped ensure excellent patient care.

Dr. Lal said, As the first in the country to work hands-on with Next Generation AIP, I have been extremely impressed with the images produced. This upgraded processor is increasing workflow, patient throughput and cath lab utilization, all while providing a safer exam for the patient, which is exactly what is needed in today's healthcare environment.

Robert Micer, director, X-ray Vascular Business Unit, Toshiba said, When we introduced Next Generation AIP, we knew it would have an immediate impact on patient care in facilities across the country. This new processor further delivers Toshiba's dedication to improving patient care, particularly for interventional procedures.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »